Diary of a Private Investor

BVXP

From over 40% cash to fully invested – at last!

Regular readers will recall that I have been 40% + in cash since shortly before the Brexit vote and subsequently stated that I would remain so until after the US election – this is very unusual for me because I am usually fully invested most of the time. As chance would have it, I was […]

, , , , , , , , , , , , , ,

Three strikes in my portfolio and a great offer from Research Tree

Those 7am RNS announcements can be nerve racking until you have seen whether one of your holdings is announcing good or bad news. This morning I thought I had hit the jackpot when three of my holdings announced excellent news: Bioventix (BVXP) announced final results today for the year ended 30th June 2016 – highlights: […]

, , , , , , , , , ,

What price quality?

I find myself in a dilemma and to some extent it is something I generally try to avoid – market timing. However, I have a significant lump of cash sitting on the sidelines and I would like to use this to double-up on some of my high conviction holdings, among them my “six of the […]

, , , , , , ,

Portfolio Restructuring

As stated in recent posts, I believe we are entering a period of high uncertainty and volatility, not just in the UK stock market but also the EU, US and currency markets. Frankly, I am not smart enough and neither do I have sufficient time to trade this volatility successfully. Therefore, I have decided to […]

, , , , , , , , , , , , ,

Portfolio Update – First Quarter to 4 July 2016

Tuesday marks the end of the first quarter of my 2016/17 portfolios (I prefer to work in tax years rather than calendar years) and the results so far make some stark reading: ISA01 – Down 6.42% (excluding dividends) Focused Income – Down 15.44% (excluding dividends) Compound Growth – Down 22.94% (excluding dividends) Special Situations – […]

, , , , , , , , ,

Share Watch: Bioventix (BVXP)

The folks at ShareSoc very kindly recorded the presentation made by Peter Harrison, CEO Bioventix, at their Richmond Supper this week. It is a very useful presentation for investors wanting to learn more about the BVXP business model, the predictability of their income streams and how they manage to achieve this without patent protection. BVXP […]

, , ,

Portfolio Commentary Part Two – Compound Growth Strategy

Over the past week I have published various portfolios; Focused Income, Compound Growth and Special Situations which combined, make up my overall equity portfolio. I have also launched an ISA portfolio to reflect and track how I invested this years’ allowance. The main reasons for dividing my overall holdings into different strategies were outlined in […]

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Pre-Holiday Update – BVXP, SRT, BKG, PHP, GVC

A few updates from my holdings over the past couple of weeks: Bioventix (BVXP.L) In my view, the company issued a positive half-yearly report on 21st March but the shares have subsequently fallen. Turnover up 23%, pre-tax profit up 33%, post tax profit up 31%, dividend up 50% and yet the shares are down. This […]

, , , , , , , , , , , , , ,

Next posts